• About
  • Subscribe
  • Advertise
  • Contact
Thursday, December 5, 2024
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home Local

Awareness of diabetic eye diseases lacking – MDFA poll

by rhiannon bowman
April 28, 2021
in Local, News
Reading Time: 3 mins read
A A
Diabetic retinopathy is the most common diabetic eye disease, affecting between 300,000 and 400,000 Australians. Image:  777 Bond vector/Shutterstock.com.

Diabetic retinopathy is the most common diabetic eye disease, affecting between 300,000 and 400,000 Australians. Image: 777 Bond vector/Shutterstock.com.

Share on FacebookShare on Twitter

A survey of Australia’s working-age population has revealed that most can’t name the most common cause of blindness among their age group – diabetic retinopathy (DR).

This is despite a higher proportion of respondents knowing that diabetes affects the eyes, compared with other body parts such as the feet, kidneys and heart.

Macular Disease Foundation Australia (MDFA) has shared the results of a YouGov poll it commissioned, showing only 29% of Aussies aged 50 to 70 have heard of DR, while only 26% are aware of diabetic macular oedema (DMO).

Dee Hopkins.

DR is the most common diabetic eye disease and the top cause of blindness in working-age Aussies, affecting between 300,000 and 400,000 people, according to MDFA. The organisation notes that around 1.7 million Australians have diabetes, and that figure is expected to climb past two million by 2025, driving a surge in diabetic eye disease.

The study was commissioned to mark Macula Month, MDFA’s annual awareness campaign each May urging at-risk Aussies to check their macula. The survey comprised 1,049 Australians aged between 50 and 70 and was conducted online between 18-22 February 2021.

“Although 82% identified the eyes as a body part that diabetes can affect – higher than feet (74%), kidneys (68%), and even the heart (53%) – the lack of awareness of what these conditions are called means many people who are at risk remain in the dark about these sight-threatening complications,” MDFA said.

MDFA CEO Dee Hopkins is concerned that most people can’t name DR.

“Diabetic retinopathy claims the eyesight of more working-age Australians than any other eye condition, yet less than 30% of people know its name,” Hopkins said.

However, more than two thirds of people polled are having regular eye checks.

“The YouGov study showed that 68% of respondents have had an eye examination and/or macula check in the last two years – more than other health checks such as cholesterol (66%), bowel cancer screenings (51%), glucose/diabetes (44%) and skin checks (36%),” MDFA said.

Dr James Muecke.

MDFA Ambassador and 2020 Australian of the Year, Adelaide ophthalmologist Dr James Muecke AM, said DR is the only reversible macular condition.

“If you control your diabetes, or if you are able to put your type 2 diabetes into remission, you can turn this blinding disease around. We want people to not only understand the name of the disease, we want everyone to take action to avoid its devastating outcome,” he said.

“This is easily done through regular eye examinations and managing your diabetes. When the disease is picked up early, you can make lifestyle changes and access good treatments that maintain sight and prevent severe vision loss.”

MDFA’s annual Macula Month awareness campaign in May will urge even more Australians to book an eye exam through the Check My Macula tool (www.CheckMyMacula.com.au).

The short online quiz reveals individual risk factors for macular disease – including diabetic eye disease – in less than a minute, then helps users make an appointment with their nearest optometrist or schedule a reminder to have an eye exam in the future.

“Tens of thousands of Australians have already taken the Check My Macula quiz, and many more will join them this Macula Month,” Hopkins said.

More reading

Shifting the dial on diabetes-related blindness

New WA children’s clinic to revolutionise diabetic eye treatment

‘People are eating themselves blind’ 

 

Tags: Dee Hopkinsdiabetesdiabetic macular oedemadiabetic retinopathyDMODRDr James MueckeMacular Disease Foundation AustraliaMDFA

Related Posts

A new WA clinic will give Aboriginal communities and others greater access to eyecare. Image: Sawoon/stock.adobe.com

New clinic will help address inequities in Aboriginal eyecare

by Staff Writer
December 5, 2024

A new eye clinic aims to make a significant impact in transforming eyecare for Aboriginal communities in Western Australia. A...

Or lack of it, depending on where you live, is the concern of the CPMC and others. Image: BJP7images/stock.adobe.com.

Health ministers warned that fast-track changes could bring ‘postcode’ health care

by Staff Writer
December 5, 2024

Australia’s state health ministers have been warned that the proposed fast-track registration of Specialist International Medical Graduates (SIMGs) risks exacerbating...

Alcon has confirmed its new Unity systems are now registered in Australia, and will be commercially available in 2025. Image: Konektus Photo/Shutterstock.com.

All-new Alcon Unity vitreoretinal and cataract systems approved in Australia

by Myles Hume
December 4, 2024

Alcon has revealed its “highly anticipated” Unity Vitreoretinal Cataract System and Unity Cataract System have been included on the Australian...

Join our newsletter

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2024 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2024 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited